Simplex Trading’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-5,800
| Closed | -$23K | – | 11678 |
|
|
2022
Q1 | $23K | Buy |
5,800
+1,600
| +38% | +$5.8K | ﹤0.01% | 8126 |
|
|
2021
Q4 | $14K | Sell |
4,200
-24,700
| -85% | -$86.4K | ﹤0.01% | 8785 |
|
|
2021
Q3 | $126K | Hold |
28,900
| – | – | ﹤0.01% | 6295 |
|
|
2021
Q2 | $126K | Buy |
28,900
+28,392
| +5,589% | +$116K | ﹤0.01% | 6405 |
|
|
2021
Q1 | $208K | Sell |
508
-376
| -43% | -$1.63K | ﹤0.01% | 4684 |
|
|
2020
Q4 | $352K | Buy |
884
+105
| +13% | +$340 | ﹤0.01% | 3870 |
|
|
2020
Q3 | $210K | Buy |
779
+612
| +366% | +$1.69K | ﹤0.01% | 4045 |
|
|
2020
Q2 | $45K | Sell |
167
-125
| -43% | -$349 | ﹤0.01% | 5598 |
|
|
2020
Q1 | $68K | Sell |
292
-968
| -77% | -$3.29K | ﹤0.01% | 4811 |
|
|
2019
Q4 | $592K | Buy |
1,260
+94
| +8% | +$385 | ﹤0.01% | 2581 |
|
|
2019
Q3 | $390K | Buy |
1,166
+422
| +57% | +$1.39K | ﹤0.01% | 2864 |
|
|
2019
Q2 | $244K | Sell |
744
-403
| -35% | -$1.17K | ﹤0.01% | 3268 |
|
|
2019
Q1 | $347K | Buy |
1,147
+335
| +41% | +$1.09K | ﹤0.01% | 3043 |
|
|
2018
Q4 | $220K | Buy |
812
+620
| +323% | +$2.04K | ﹤0.01% | 3070 |
|
|
2018
Q3 | $64K | Buy |
192
+86
| +81% | +$266 | ﹤0.01% | 4919 |
|
|
2018
Q2 | $27K | Buy |
106
+2
| +2% | +$5 | ﹤0.01% | 5636 |
|
|
2018
Q1 | $5K | Buy |
+104
| New | +$234 | ﹤0.01% | 4702 |
|
Other funds holding ATRS
Simplex Trading's ATRS Position: Q2 2022 in Review
Simplex Trading sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 25,514 shares — an estimated $104K sold.
Simplex Trading first reported a position in ATRS in Q3 2015 and held it in 20 quarters. The position peaked at $295K in Q2 2019. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- Simplex Trading reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- Simplex Trading sold 25,514 Antares Pharma, Inc. shares in Q2 2022, an estimated $104K.
- Simplex Trading first reported a position in Antares Pharma, Inc. in Q3 2015 and held it in 20 quarters.
- Simplex Trading's Antares Pharma, Inc. position peaked at $295K in Q2 2019.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on Simplex Trading's 13F filing for Q2 2022, filed 3 Aug 2022.